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ABSTRACT
Background. This study examined the relationships between self-reported childhood sexual abuse
(CSA) and drug-related outcomes in an Australian twin panel.
Method. A semi-structured psychiatric interview was conducted in 1996–2000 by telephone with
young adult Australian twins (mean age 29.9 years). Data reported here are from 6050 twins who
responded to both CSA and drug-related items.
Results. A history of CSA was associated with signiﬁcant risk for subsequently occurring regular
smoking and use of each illicit drug class. Further CSA-associated risk was found among regular
users, for nicotine and alcohol dependence, and among illicit drug users, for abuse/dependence of
most drug classes. In same-sex discordant pairs, signiﬁcant risk for regular smoking and illicit drug
use was found in twins with a history of CSA compared to their non-abused co-twins. Similar
analyses for abuse/dependence found signiﬁcant risk for opioids, any illicit drug, and any non-
cannabis illicit drug. CSA was associated with signiﬁcantly earlier drug use. Despite the association
of CSA with risk for early-onset cannabis use and regular smoking, risks for illicit drug outcomes
associated with CSA and with either form of early-onset use combine in near-additive fashion.
Conclusions. CSA is associated with risk for subsequently occurring regular smoking and illicit
drug use and abuse/dependence. Risks for drug use are mildly attenuated with control for familial
contributions; similar risks for abuse/dependence remain signiﬁcant for opioids and for illicit drugs
combined across classes. Although we found evidence of earlier onset drug use with CSA, risks
associated with CSA and with early-onset use combine in a largely additive manner.
INTRODUCTION
A high prevalence of childhood abuse has been
reported in samples of adolescents (Harrison
et al. 1989; Clark et al. 1997) and adults
(Bartholomew et al. 2002; Simpson & Miller,
2002) receiving substance use disorders (SUDs)
treatment. Although maltreatment occurs in
various forms, childhood sexual abuse (CSA) is
the most studied (Simpson & Miller, 2002). In
adolescents receiving SUDs treatment, a history
of CSA was associated with earlier initiation of
licit and illicit drug use (Harrison et al. 1989).
Similarly, earlier injection drug use occurs in
adult injection drug users with a history of CSA
(Ompad et al. 2005).
Ethically and legally mandated reporting has
caused investigators to reject prospective, natu-
ralistic examinations for other research designs.
Anonymous, questionnaire-based assessment of
large, school-ascertained samples (Harrison
et al. 1997; Bensley et al. 1999) have found
CSA-associated risk for licit and illicit substance
use including earlier initiation and greater
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frequency of use. Given that Lynskey et al.
(2003) found early-onset cannabis use (i.e. prior
to age 17) to be a signiﬁcant risk factor for use
and abuse/dependence of other illicit drugs in
their sample, CSA-associated earlier onset sub-
stance use could also be a source of risk for these
more distal outcomes.
Examinations in general population samples
that have obtained CSA history by retrospective
report from young adults have conﬁrmed associ-
ations with substance dependence (Mullen
et al. 1993; Fergusson et al. 1996b ; Molnar et al.
2001). However, reports have also noted that
parental SUDs are associated with signiﬁcant
risk for oﬀspring CSA (Fergusson et al. 1996b ;
Fleming et al. 1997; Nelson et al. 2002; Walsh
et al. 2003). As SUDs are known to be moder-
ately heritable (Heath et al. 1997; Tsuang &
Lyons, 1998; Kendler et al. 2003), it is possible
that parental SUDs may be a source of risk
in oﬀspring for both CSA and drug-related
outcomes. Unfortunately, investigations in gen-
eral population samples have included limited
assessment of, and control for, parental psycho-
pathology.
Twin studies (Kendler et al. 2000; Nelson
et al. 2002) enable additional methods of con-
trolling for familial background while estimat-
ing adversity-associated risk. Because twins
share family background risk factors, co-twin
control comparisons made in CSA-discordant
pairs provide a useful means of estimating
CSA-associated risk. Optimally, comparisons
limited to monozygotic (MZ) twins would
enable complete control for genetic and family
environmental risk factors. However, because
only data from pairs discordant for both CSA
and the examined outcome are informative
for these analyses, sample size limitations gen-
erally necessitate including discordant dizygotic
(DZ) pairs (Kendler et al. 2000; Nelson et al.
2002).
Kendler et al. (2000) assessed CSA history by
a mailed questionnaire and substance depen-
dence by an in-person interview in adult female
twins. They found CSA-associated risks for
alcohol and any illicit drug dependence that
remained signiﬁcant, with inclusion of family
functioning measures as covariates. The risks
were greatest when CSA involved intercourse.
They examined risks in CSA-discordant pairs in
analyses that incorporated varying degrees of
CSA and discordance. All odd ratios were
greater than unity for alcohol dependence (half
reached signiﬁcance). For drug dependence,
most risks fell below signiﬁcance, presumably
limited by the small numbers (5–15) of doubly-
discordant pairs.
The current report examines the relationship
between CSA and licit and illicit drug outcomes
in a large Australian young adult twin cohort.
We extend ﬁndings from previous reports by:
(1) providing separate estimates of risk for two
classes of licit drugs and ﬁve classes of illicit
drugs ; (2) excluding individuals whose use of the
speciﬁc drug being examined predated their ﬁrst
occurrence of CSA; (3) separately estimating
CSA-associated risks for (a) drug use and (b)
drug-related disorders among users ; (4) using a
large sample of CSA-discordant twins to esti-
mate CSA-associated risks controlling for fam-
ily background factors ; and (5) estimating the
risks associated with CSA only, early-onset
substance use only, and both in combination,
and examining whether a signiﬁcant interaction




The young adult cohort of the Australian Twin
Register is a volunteer panel composed of twins
born 1964–1971 (Heath et al. 2001; Nelson
et al. 2002; Lynskey et al. 2002, 2003; Knopik
et al. 2004). Nearly all were registered by
parents between 1980 and 1982 in response to
approaches through school systems or mass
media. Twins were recontacted and verbal con-
sent obtained according to the protocol ap-
proved by the institutional review boards of
Washington University School of Medicine and
the Queensland Institute of Medical Research.
Data reported here were collected between 1996
and 2000 by a comprehensive telephone assess-
ment administered to all consenting cohort
members by trained lay interviewers.
Of 4010 pairs that could be traced, interviews
were completed with both members of 2765
pairs (69% pairwise response rate) and one
member of 735 pairs (78% individual response
rate). The current sample includes all 6050
individuals with data available for both CSA
and drug use. The sample is 55.5% female;
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mean age is 29.9 years (S.D.=2.5). The edu-
cational background of the sample suggests no
major social class bias : 45.6% did not graduate
from high school, 20.3% had a high school
diploma without post-secondary education,
and 34.1% had some post-secondary education.
The prevalence and characteristics of CSA in
this cohort have been observed (Nelson et al.
2002) to resemble general population reports
(Fergusson et al. 1996b ; Fleming, 1997; Holmes
& Slap, 1998). The rates of illicit drug use
are similar to those reported in an Australian
epidemiological study (Australian Institute of
Health and Welfare, 1999).
Assessment of illicit drug-related outcome
measures
A standardized psychiatric diagnostic assess-
ment adapted from the Semi-Structured As-
sessment for the Genetics of Alcoholism
(SSAGA; Bucholz et al. 1994) was administered
by telephone. The interview enabled lifetime
DSM-IV (APA, 1994) diagnoses including nic-
otine (cigarettes only) dependence and alcohol
dependence. Regular use of nicotine (at least
weekly for 3 consecutive weeks) and alcohol (at
least monthly for 6 consecutive months) was
also queried.
The interview’s illicit drug section assessed
two of four abuse criteria and four of seven de-
pendence criteria. Drug use disorders were
operationalized according to Lynskey et al.
(2002, 2003) (i.e. abuse as endorsement of either
abuse criterion; probable dependence as en-
dorsement of two or more dependence criteria).
The abuse assessment, though diagnostic, would
miss cases with maladaptive use limited to
non-assessed categories. The non-diagnostic
dependence assessment has excellent sensitivity
and speciﬁcity for DSM-IV drug dependence
(Lynskey et al. 2002, 2003). We combined abuse
and dependence within each drug class as in
Lynskey et al. (2003). We examined use (i.e.
any whatsoever) and abuse/dependence of ﬁve
classes of illicit drugs: (1) cannabis ; (2) opiates;
(3) sedatives (including benzodiazepines and
barbiturates) ; (4) stimulants ; and (5) cocaine.
For the discordant pair analyses, two composite
variables were coded to reﬂect the use of any,
and any non-cannabis, illicit drug. Composite
variables were similarly coded for any, and any
non-cannabis, illicit drug abuse/dependence.
Early-onset use was deﬁned as occurring before
age 17 years for cannabis (Lynskey et al. 2003)
and before age 16 for regular smoking.
Assessment of CSA
A composite variable for CSA was derived from
ﬁve component questions (Nelson et al. 2002) :
(1) Before age 18, were you ever forced into
sexual intercourse or any other form of sexual
activity? (2) Before you were 16 years old, were
there any sexual contacts between you and
anyone other than a family member who was 5
or more years older than you were? By sexual
contact I mean their touching your sexual parts,
you touching their sexual parts, or sexual inter-
course (coded positively where subjects re-
sponded to a follow-up question that contact
was ‘ever forced’). (3) Before you were 16 years
old, were there any sexual contacts between
you and any family members, like a parent or
step-parent, grandparent, uncle, aunt, brother
or sister, or cousin? By sexual contact I mean
their touching your sexual parts, you touching
their sexual parts, or sexual intercourse (coded
positively where subjects responded to further
questions that contact involved either an adult
or the use of force by a child). The ﬁnal two
questions contain descriptions in parentheses
that were not read aloud to protect con-
ﬁdentiality (they appeared in a booklet mailed
to respondents). This section was skipped if re-
spondents misplaced their booklets. (4) How
about event no. 5 [You were raped (someone
had sexual intercourse with you when you did
not want to, by threatening you or using some
degree of force)]? (Included within CSA when
ﬁrst occurred before age 18.) (5) Apart from
event no. 5 did event no. 6 [You were sexually
molested (someone touched or felt your genitals
when you did not want them to)] ever happen to
you? A binary CSA variable was coded positive
with endorsement of any of these items. Data
were excluded from individuals who reported an
onset o18 years for all endorsed CSA items or
from those refused to respond to a CSA com-
ponent question without endorsing another
component item. Data from nine individuals
missing CSA onset were excluded from analyses
requiring onset information. Although age 17 is
the highest upper limit commonly used for CSA
onset, our sample’s mean onset is similar to
values observed in general population samples.
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Data analysis
We used SAS (SAS Institute, 2000) and the
Stata Statistics and Data Analysis Package ver-
sion 6.0 (Stata Corporation, 1999) for analyses.
An a-level of 0.05 was required for signiﬁcance.
The robust variance estimator option in STATA
adjusted all 95% conﬁdence intervals (CIs) for
the statistical non-independence of observations
from twin pairs.
We calculated the prevalence of drug use, by
CSA history, in women and men. We calculated
the prevalence, by CSA history, of licit drug
dependence in regular users, and illicit drug
abuse/dependence in (ever) users.
We performed survival analysis using Cox
proportional hazard regression models to esti-
mate the CSA-associated risk, controlling for
gender, for regular licit drug use and use of each
illicit drug class. These analyses treated CSA as
a time-dependent covariate to calculate hazard
ratios, estimating outcome risks associated
with the prior experience of CSA. We similarly
examined the risk with the prior experience of
CSA, controlling for gender, for: (1) licit drug
dependence, limited to regular users ; and (2)
illicit drug abuse/dependence, limited to users
of that drug class, using the age at ﬁrst use for
each drug as a conservative estimate for abuse/
dependence onset (not obtained).
We performed discordant pair analyses using
conditional logistic regression to estimate the
risk in CSA-positive versus CSA-negative pair
members to examine CSA-associated risks con-
trolling for the contribution of familial factors.
Data from DZ opposite-sex pairs were excluded
to eliminate bias due to gender diﬀerences
in substance use and CSA prevalence. The re-
maining same-sex CSA-discordant pairs (n=
280) included 96 MZ female, 111 DZ female,
31 MZ male and 42 DZ male pairs. Only data
from doubly-discordant pairs (i.e. discordant
for both CSA and the outcome being examined)
are informative for these analyses. Odds ratios
(ORs) are easily calculated as the ratios of the
number of pairs in which the twin with a history
of CSA is also outcome-positive (n21) to pairs in
which the twin reporting CSA is outcome-
negative (n12). The outcomes examined included
the regular use of licit drugs and the use and
abuse/dependence of illicit drugs of the various
classes, any illicit drug, and any non-cannabis
illicit drug. We excluded pairs in which the
CSA-positive twin reported ﬁrst use of the illicit
drug being examined predated CSA onset. We
report n21 and n12 separately by zygosity with
ORs and 95% CIs only for the combined group.
We used an option in STATA to test whether the
risk estimates diﬀered by zygosity or gender and
reported values separately when we found sig-
niﬁcant interactions.
To test for the contribution of CSA to the age
at onset of drug use, we ﬁt a series of linear re-
gression models that controlled for gender for
which all values are in units of age (years). The
intercept is the mean onset for CSA-negative
women, and regression coeﬃcients represent
the incremental changes associated with CSA
and male gender. We excluded individuals
whose ﬁrst use of the examined drug predated
CSA onset. We used logistic regression to
examine the CSA-associated risk, controlling
for gender, for early-onset cannabis use. We
coded dummy variables to represent a history of
both CSA and early-onset cannabis use, CSA
without early-onset cannabis use, or early-onset
cannabis use without CSA for use in logistic re-
gression analyses examining the risk for use and
abuse/dependence of the illicit drug classes,
controlling for gender. Additional logistic re-
gression analyses that included main eﬀects for
gender, CSA, and early-onset cannabis use
and an interaction term (CSArearly-onset
cannabis use) evaluated whether signiﬁcant
interactions were found. We repeated these
analyses substituting early-onset regular smok-
ing for early-onset cannabis use and including
cannabis outcomes as dependent variables.
RESULTS
A history of CSA was reported by 17.4% of
women and 6.0% of men (OR 3.31, 95% CI
2.73–4.00). CSA began early [mean age 10.7
years (S.D.=4.09)] and was preceded uncom-
monly by regular licit drug use and rarely by
illicit drug use (regular smoking preceded CSA
in 69 of 477 individuals reporting both; the
similar ratios for other substances are : regular
alcohol use 30/643; cannabis use 24/542; opioid
use 0/101; sedative use 5/145; stimulant use
3/245; and cocaine use 0/92).
Women and men with a history CSA more
commonly reported regular smoking and use of
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each class of illicit drug examined, but not reg-
ular alcohol use (Table 1). Survival analysis re-
vealed that, controlling for gender, a history of
CSA is associated with signiﬁcant risk for sub-
sequently occurring regular smoking and use of
all examined classes of illicit drugs (Table 2).
The strongest eﬀects were observed for opioids,
sedatives and cocaine, the least prevalent drug
classes. CSA is thus associated with signiﬁcant
risk for regular smoking and cannabis use, two
fairly normative behaviours in our sample, but
not with the almost ubiquitous regular alcohol
use. Greater risk is observed for use of the less-
prevalent illicit drugs.
Among regular users, a history of CSA was
found by survival analysis to be associated with
risk for nicotine and alcohol dependence.
Similarly, among those reporting illicit drug
use, a history of CSA was associated with sig-
niﬁcant risk for subsequently occurring abuse/
dependence of each examined class of drugs
other than cocaine; the strongest eﬀects were
observed for opioids and sedatives. Among
those who have initiated substance use, CSA-
associated risk for substance use disorders is
observed.
In CSA-discordant same-sex pairs, signiﬁcant
risk for regular smoking and use of cannabis,
opioids, sedatives and cocaine was seen in twins
reporting a history of CSA compared to their
non-sexually abused co-twins; the risk for
stimulant use fell just below signiﬁcance
(Table 3). Analyses that combined drug cat-
egories found signiﬁcant risk in the twins with a
history of CSA compared to their non-abused
co-twins for any illicit drug use and any non-
cannabis illicit drug use. In similar examinations
of drug abuse/dependence, risk estimates ex-
ceeded unity for all drug classes, but reached
signiﬁcance only for opioids (OR 6.50). Sig-
niﬁcant abuse/dependence risk was found for
any illicit drug (OR 1.78) and any non-cannabis
Table 1. Comparison of the prevalence (%) of licit and illicit substance outcomes by gender
and childhood sexual abuse (CSA) status
Women (n=3357) Men (n=2693) Women Men
CSA+ CSAx CSA+ CSAx CSA+ CSAx CSA+ CSAx
Licit Regular use Dependence (among regular users)
Nicotine 63.8 47.8 68.9 52.5 66.1 53.3 77.5 59.2
Alcohol 85.9 86.3 92.6 93.0 32.7 14.9 45.0 32.1
Illicit Any use Abuse/dependence (among users)
Cannabis 71.7 49.0 82.0 67.8 34.9 19.4 50.0 34.8
Opioids 11.5 4.2 23.0 6.8 37.3 16.2 29.7 10.5
Sedatives 18.0 6.9 27.3 7.7 14.3 6.3 27.3 7.7
Stimulants 29.2 13.8 49.1 24.0 24.1 16.9 32.9 20.4
Cocaine 9.1 3.9 25.5 7.2 11.3 7.3 12.2 10.4
Table 2. Hazard ratios (and 95% conﬁdence intervals, in parentheses) reﬂecting the risk for
licit and illicit substance outcomes associated with the prior experience of childhood sexual abuse
(CSA), controlling for male gender (n=6050)
CSA Male CSA Male
Licit Regular use Dependence (among regular users)
Nicotine 1.49 (1.32–1.67) 1.13 (1.05–1.23) 1.49 (1.31–1.69) 1.22 (1.11–1.34)
Alcohol 1.06 (0.97–1.15) 1.38 (1.31–1.45) 1.99 (1.71–2.33) 2.19 (1.95–2.46)
Illicit Any use Abuse/dependence (among users)
Cannabis 1.73 (1.57–1.92) 1.62 (1.51–1.74) 1.73 (1.46–2.05) 1.84 (1.61–2.10)
Opioids 3.09 (2.43–3.95) 1.70 (1.37–2.11) 2.60 (1.60–4.22) 0.65 (0.40–1.06)
Sedatives 3.00 (2.44–3.69) 1.21 (1.00–1.46) 2.61 (1.43–4.78) 1.46 (0.80–2.64)
Stimulants 2.28 (1.96–2.66) 1.82 (1.61–2.06) 1.54 (1.13–2.11) 1.27 (0.98–1.65)
Cocaine 2.89 (2.25–3.71) 2.08 (1.66–2.60) 1.22 (0.58–2.53) 1.27 (0.66–2.44)
Values are in bold face where hazard ratio is signiﬁcant (p<0.05).
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illicit drug (OR 2.18). Using data from discor-
dant same-sex pairs to control for familial con-
tributions to risk, persistent CSA-associated
risk is seen for regular smoking, use of most
classes of illicit drugs, and abuse/dependence of
opioids, any illicit drug, and any non-cannabis
illicit drug.
Separate discordant pair analyses (results not
shown) performed to determine whether risk
estimates diﬀered by zygosity found signiﬁ-
cantly greater risk in DZ (OR 4.20, 95% CI
1.58–11.14) than in MZ pairs (OR 0.75, 95% CI
0.26–2.16) only for opioid use. Similar analyses
found signiﬁcant gender diﬀerences only for
cocaine use, with greater risk in male (OR 13.00,
95% CI 1.70–99.36) than in female (OR 1.25,
95% CI 0.49–3.17) pairs.
Regression analyses found a signiﬁcant con-
tribution for a history of CSA, controlling for
gender, to age at onset of regular nicotine and
alcohol use (Table 4). Similar eﬀects on the age
at ﬁrst use of illicit drugs were seen for all drug
classes, but fell below signiﬁcance for sedatives
and cocaine; the largest eﬀects were observed
for cannabis and opioids. We examined whether
a history of CSA was also associated with risk
for early-onset cannabis use (Lynskey et al.
2003) and found signiﬁcant risk (OR 2.93, 95%
CI 2.41–3.58), controlling for male gender (OR
2.03, 95% CI 1.72–2.40). These data conﬁrm
that CSA is associated with risk for earlier sub-
stance use onset.
An examination of the risks for the use of the
other drug classes associated with both CSA
and early-onset cannabis use, CSA alone, early-
onset cannabis use alone, and male gender
found signiﬁcantly greater risk for the use of all
examined classes of illicit drugs associated with
a history of both CSA and early-onset cannabis
use than with either risk factor alone (Table 5).
A similar examination of the risks for abuse/
dependence of the other illicit drugs classes ob-
served greater risk associated with the presence
of both CSA and early-onset cannabis use.
Additional examinations revealed no signiﬁcant
interaction (CSArearly-onset cannabis use) in
any model (all p values >0.10). Thus, in those
reporting both CSA and early-onset cannabis
use, the risks associated with either factor alone
combine in a near-additive fashion (i.e. the
Table 3. Comparison of drug use and abuse/dependence in CSA+ versus CSAx members of




OR (95% CI)MZ DZ Combined
Licit – regular use
Nicotine 17/7 28/19 45/26 1.73 (1.07–2.81)
Alcohol 7/8 12/7 19/15 1.27 (0.64–2.49)
Illicit – any use
Cannabis 19/17 29/12 48/29 1.66 (1.04–2.62)
Opioids 6/8 21/5 27/13 2.08 (1.07–4.03)
Sedatives 15/9 23/11 38/20 1.90 (1.11–3.27)
Stimulants 18/9 24/17 42/26 1.62 (0.99–2.63)
Cocaine 9/4 14/5 23/9 2.56 (1.18–5.52)
Any illicit drug 22/13 29/14 51/27 1.89 (1.19–3.01)
Non-cannabis illicit drug 23/11 36/22 59/33 1.79 (1.17–2.74)
Illicit – abuse/dependence
Cannabis 11/11 21/14 32/25 1.28 (0.76–2.16)
Opioids 5/1 8/1 13/2 6.50 (1.47–28.80)
Sedatives 3/0 6/2 9/2 4.50 (0.97–20.83)
Stimulants 7/3 12/8 19/11 1.73 (0.82–3.63)
Cocaine 2/1 4/2 6/3 2.00 (0.50–8.00)
Any illicit drug 14/8 27/15 41/23 1.78 (1.07–2.97)
Non-cannabis illicit drug 8/3 16/8 24/11 2.18 (1.07–4.45)
CSA, Childhood sexual abuse; MZ, monozygotic ; DZ, dizygotic; OR, odds ratio; CI, conﬁdence interval. n21, the number of
doubly-discordant pairs in which the twin reporting CSA is also outcome-positive ; n12, the number of doubly-discordant pairs in which the
twin reporting CSA is outcome-negative.
OR and 95% CI are for combined MZ and DZ same-sex pairs.
Values are in bold face where OR is signiﬁcant (p<0.05).
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absence of any interaction reaching signiﬁcance
indicates that the risks associated with CSA and
with early cannabis use combine in a manner
that does not signiﬁcantly diﬀer from additive).
We conducted a similar set of analyses for
early-onset regular smoking (before age 16),
ﬁnding signiﬁcant CSA-associated risk (OR
2.38, 95% CI 1.99–2.85), controlling for male
Table 4. Results of multivariate regression analyses examining the contribution of childhood
sexual abuse (CSA) status and gender to the onset of substance use
Intercept (95% CI)
Regression coeﬃcients (95% CI)
CSA status Male
Licit – regular use
Nicotine (n=3063) 16.77 (16.60–16.93) x0.47 (x0.79 tox0.14) x0.28 (x0.51 tox0.05)
Alcohol (n=5363) 18.62 (18.51–18.73) x0.27 (x0.52 tox0.02) x0.78 (x0.93 tox0.63)
Illicit – use
Cannabis (n=3588) 19.43 (19.24–19.62) x0.86 (x1.19 tox0.52) x0.78 (x1.02 tox0.54)
Opioids (n=386) 22.33 (21.60–23.06) x1.12 (x2.16 tox0.09) 0.09 (x0.80 to 0.97)
Sedatives (n=523) 21.88 (21.27–22.50) x0.42 (–1.36 to 0.51) x0.86 (x1.69 tox0.03)
Stimulants (n=1231) 21.37 (21.02–21.73) x0.69 (x1.25 tox0.13) x0.02 (x0.45 to 0.41)
Cocaine (n=381) 23.01 (22.35–23.67) x0.47 (–1.41 to 0.47) 0.64 (x0.15 to 1.43)
CI, Conﬁdence interval.
Values are in bold face where regression coeﬃcient diﬀers signiﬁcantly from zero (p<0.05).
Table 5. The contributionsa to the risk for use and abuse/dependence of illicit drugs from childhood















Opioids 7.93 (5.46–11.51) 3.02 (2.19–4.16) 3.36 (2.56–4.40) 1.57 (1.25–1.97)
Sedatives 9.19 (6.53–12.92) 3.13 (2.36–4.14) 4.26 (3.35–5.42) 1.06 (0.86–1.30)
Stimulants 9.93 (7.27–13.56) 2.23 (1.79–2.79) 4.65 (3.88–5.57) 1.79 (1.55–2.08)
Cocaine 11.62 (7.99–16.89) 2.52 (1.73–3.66) 5.38 (4.15–6.97) 1.82 (1.42–2.34)
Abuse/dependence
Opioids 22.93 (11.91–44.16) 7.11 (3.68–13.76) 4.93 (2.57–9.47) 1.06 (0.63–1.77)
Sedatives 32.20 (14.15–73.26) 9.80 (4.30–22.34) 7.21 (3.18–16.34) 1.66 (0.85–3.21)
Stimulants 11.11 (7.15–17.26) 2.83 (1.85–4.34) 4.80 (3.50–6.60) 1.89 (1.43–2.51)
Cocaine 27.15 (10.69–68.97) 2.03 (0.43–9.63) 11.11 (5.02–24.58) 2.01 (0.98–4.12)
Substance-related
outcome











Cannabis 7.97 (5.26–12.08) 2.21 (1.80–2.72) 3.28 (2.73–3.93) 2.11 (1.97–2.38)
Opioids 6.71 (4.66–9.65) 3.00 (2.15–4.19) 2.43 (1.87–3.17) 1.69 (1.35–2.12)
Sedatives 7.82 (5.71–10.70) 3.04 (2.27–4.06) 2.84 (2.26–3.56) 1.15 (0.94–1.40)
Stimulants 5.67 (4.24–7.58) 2.51 (2.01–3.15) 2.69 (2.28–3.17) 1.93 (1.67–2.23)
Cocaine 6.06 (4.12–8.92) 2.87 (2.03–4.06) 2.35 (1.80–3.07) 2.07 (1.63–2.63)
Abuse/dependence
Cannabis 7.80 (5.81–10.48) 2.52 (1.97–3.21) 3.40 (2.85–4.05) 2.69 (2.30–3.15)
Opioids 18.90 (9.31–38.37) 9.26 (4.73–18.12) 4.56 (2.41–8.63) 1.16 (0.70–1.93)
Sedatives 25.17 (11.24–56.38) 10.49 (4.76–23.11) 4.98 (2.20–11.23) 1.86 (0.98–3.54)
Stimulants 9.75 (6.41–14.84) 2.57 (1.68–4.20) 3.36 (2.47–4.58) 2.09 (1.58–2.76)
Cocaine 11.27 (4.40–28.91) 2.97 (0.93–9.48) 3.31 (1.53–7.15) 2.46 (1.23–4.94)
a Analyses control for gender; odds ratios and 95% conﬁdence intervals are reported.
Values are in bold face where the odds ratio is signiﬁcant (p<0.05).
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gender (OR 1.39, 95% CI 1.20–1.61). We found
a similar pattern of risks associated with either
CSA or early-onset regular smoking alone or
both in combination for outcomes that ad-
ditionally included cannabis use and abuse/
dependence (Table 5). Further analyses again
conﬁrmed the absence of signiﬁcant interac-
tions. The risks associated with a history of
CSA, and with early-onset substance use, for the
use and abuse/dependence of illicit drugs appear
to be largely additive.
DISCUSSION
Our analyses strongly support the association of
CSA with risk for licit and illicit drug-related
outcomes. We found that CSA is associated
with risk for subsequently occurring drug use
and, among users, for drug-related disorders. In
analyses limited to CSA-discordant same-sex
pairs in which the non-abused co-twin served
as a control for the contribution of familial
factors, we found similar CSA-associated risks
for substance use. Similar examinations re-
vealed signiﬁcant risk only for opioid, any illicit
drug, and any non-cannabis illicit drug abuse/
dependence. Although we found CSA to be a
risk factor for earlier initiation of substance
use, we observed that risks for illicit drug
use and abuse/dependence associated with CSA
combine in a largely additive manner with
those from either early-onset cannabis use or
early-onset regular smoking (i.e. no signiﬁcant
interaction).
Our ﬁndings are very consistent with prior
studies that have examined the association of
CSA with licit and illicit drug outcomes. Large,
anonymous, school-based assessments of ado-
lescents found CSA-associated risk for licit
and illicit drug use, including the use of multiple
classes of drugs (Harrison et al. 1997; Bensley
et al. 1999). High CSA prevalence has been
consistently reported in substance abuse treat-
ment samples (Simpson & Miller, 2002).
Signiﬁcant associations with alcohol and drug
abuse and dependence have been observed in
community samples of young adults (Mullen
et al. 1993; Fergusson et al. 1996a) and in the
National Comorbidity Survey sample (Molnar
et al. 2001). Our results describe CSA-associated
risks more comprehensively: (1) for the sub-
sequent occurrence of both drug use and,
among users, of drug-related disorders,
(2) extending to both licit and illicit drug-related
outcomes, and (3) of greatest magnitude for
outcomes involving opioids and sedatives.
Our report is the ﬁrst to examine drug use in
CSA-discordant male and female same-sex twin
pairs. Reporting on the largest CSA-discordant
pair sample to date, we found that regular
smoking and use of each class of drugs (the re-
sult for stimulants fell just below signiﬁcance)
are reported more frequently by twins with a
history of CSA than their non-abused co-twins.
Given the consistency of our discordant pair
and survival analysis results, we conclude that
CSA-associated risks for regular smoking and
illicit drug use are only mildly attenuated with
co-twin control for the contributions of familial
risk factors.
We previously reported signiﬁcant CSA-
associated risks for nicotine dependence and
alcohol dependence in discordant pair analyses
of this sample’s data (Nelson et al. 2002). In
similar analyses, Kendler et al. (2000) observed
some signiﬁcant risk for (any illicit) drug de-
pendence and more consistent risk for alcohol
dependence. As noted, their analyses had lim-
ited power. For most classes of illicit drugs, we
probably faced similar limitations as best ex-
empliﬁed by the non-statistically signiﬁcant
OR of 4.5 for sedative abuse/dependence. The
signiﬁcant risks that we found for abuse/
dependence combined across all drug classes,
and for non-cannabis illicit drugs, suggest lim-
ited power for individual drug classes and are
inconsistent with ﬁndings due to diﬀering drug
preferences between pair members.
Our ﬁnding of earlier drug use associated
with CSA is consistent with prior reports.
Earlier initiation of licit and illicit drug use has
been reported for adolescents with a history
of CSA assessed in either school (Harrison et
al. 1997; Bensley et al. 1999) or treatment
(Harrison et al. 1989) settings. Earlier injection
drug use by those with a history of CSA has
been reported in human immunodeﬁciency virus
(HIV)-seropositive men (Holmes, 1997) and
male and female injection drug users (Ompad
et al. 2005). Our results examining the combined
eﬀects of CSA and early-onset regular smok-
ing or cannabis use suggest that individuals
with a history of CSA who develop early-
onset substance use are at very high risk for
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progression to other illicit drug use and abuse/
dependence.
Additional study is needed to determine
whether this progression can be prevented by
identifying these individuals and intervening.
Given that CSA-associated risks are likely to
arise from a variety of sources, determining the
best routes for intervention could prove chal-
lenging. Education could increase risk aware-
ness, facilitating delayed substance use and
progression. Community eﬀorts could provide
safe, supportive and substance-free alternatives
to the dangerous, harsh or substance-laden
home and extra-familial environments in which
victimization often occurs. Treatment aimed at
limiting psychiatric sequelae and attempted self-
medication could diminish risk associated with
emergent aﬀective and anxiety disorders.
Psychotherapy, in conjunction with the above,
could aid formation of healthy relationships
with contemporary peers, thereby slowing tran-
sitions to adult roles.
It is becoming increasingly clear that attempts
at parsing risk to genetic and environmental
components underestimate the complex bio-
logical underpinnings. Persistent alterations in
stress responsivity have been observed in
women with a history of CSA (Heim et al. 2000,
2001) and in adult rats repetitively separated as
pups from their dams (Caldji et al. 1998, 2000).
The latter also display long-lasting changes in
morphine sensitization, tolerance and with-
drawal (Kalinichev et al. 2001, 2002) and have
reduced levels of both gamma-aminobutyric
acid type A (GABAA) and central benzodi-
azepine receptors in regions implicated in
hypothalamic–pituitary–adrenal (HPA) axis
regulation (Caldji et al. 1998, 2000). Thus,
exposure to severe early trauma may lead to
persistent alterations in gene expression. Fur-
thermore, reports (Caspi et al. 2002, 2003) of
signiﬁcant GrE interactions involving child-
hood abuse and functional genetic polymorph-
isms for related outcomes (i.e. depression and
antisocial behaviour) have had replications
published (Eley et al. 2004; Foley et al. 2004;
Kaufman et al. 2004; Kendler et al. 2005).
Therefore, risk associated with a severe stressor
is likely to alter gene expression, which, in gen-
etically predisposed individuals, may be associ-
ated with risk for more distal sequelae. Similar
investigations targeting risk for SUDs are
clearly warranted and should incorporate re-
cently reported additional layers of complexity
(i.e. mitigation of risk with social support and
gene–gene interaction) (e.g. Kaufman et al.
2006).
A variety of limitations must be considered
when interpreting our results. As the twins were
initially recruited as children, their parents may
have been less likely to volunteer twins with a
history of CSA. However, because more severe
CSA is associated with greater risk for sub-
stance use and dependence (Mullen et al. 1993;
Fergusson et al. 1996a ; Kendler et al. 2000), any
eﬀect would probably have reduced associa-
tions. The similarity of our prevalence rates
to those obtained in community samples
(Fergusson et al. 1996b ; Fleming, 1997; Holmes
& Slap, 1998) suggests that our sample is
reasonably representative. CSA is a complex
construct ; our use of a single binary variable is
an oversimpliﬁcation that may have led to
underestimated CSA-associated risks. We chose
to do so both to simplify interpretation of the
discordant pair comparisons and because of
limitations in our CSA assessment. Physical
abuse (PA) is often present with CSA in families
(Fleming et al. 1997; Dong et al. 2003; Walsh
et al. 2003) and has also been associated with
risk for drug-related outcomes (Simpson &
Miller, 2002). We narrowed our focus to CSA
largely because our PA assessment was much
more limited. Additional analyses that incor-
porated PA with CSA into a more general con-
struct, childhood abuse, yielded very similar
results throughout (available on request), sug-
gesting that the risks we observed probably
extend beyond CSA to include PA. Our use
of retrospective self-report data, while another
potentially important source of bias, is largely
unavoidable. One examination (Fergusson et al.
2000) of the stability of CSA reports found no
relationship between variations in reports and
psychiatric status before, during or after the
reported abuse.
Despite the considerable size of our sample,
power limitations impacted the signiﬁcance
of our discordant pair ﬁndings. We opted to
combine data from pairs of diﬀerent zygosity
and sex to avoid further reductions in power.
This makes interpretation of our ﬁndings less
straightforward than analyses limited to MZ
pairs (which completely control for genetic and
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family environmental risk factors). However, it
is important to recognize that even analyses
limited to discordant MZ pairs cannot exclude
the possibility of ﬁndings arising from a
proximal latent factor (e.g. a diﬀerence in foetal
environment) associated with risk for both
variables in the model. Conversely, because the
signiﬁcant interactions involving covariates
arose from analyses that further subdivided
relatively small numbers of doubly-discordant
pairs, we believe that they require replication.
However, the signiﬁcant interaction involving
gender could reﬂect diﬀerential use patterns
because, among the illicit drugs, the greatest risk
in males was seen for cocaine. Similarly, an
interaction involving zygosity could occur if a
heritable trait (e.g. conduct disorder) is associ-
ated with increased risk for CSA and for
opioid use. Our use of age 17 as the cut-oﬀ for
CSA may have led to a more heterogeneous
construct that included both early childhood
molestation and adolescent victimization (e.g.
date rape), to which heritable risks could be
contributing. As participants remain at risk for
drug-related outcomes, risks due to an earlier
onset in CSA-positive twins may decrease over
time.
In summary, our results strongly support
the association between CSA and subsequently
occurring licit and illicit drug outcomes. Our
results conﬁrm an earlier onset of regular licit
and illicit drug use with CSA while ﬁnding no
signiﬁcant interaction between risks associated
with CSA and with early-onset substance
use. Further studies are needed to explore
potential biological underpinnings (e.g. GrE
interactions) and to determine whether risks
for drug-related outcomes can be mitigated
by identifying ‘at-risk’ individuals early and
intervening.
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